Immunobiology of Genital Warts and Molluscum Contagiosum

  • M. A. Stanley
  • J. D. Oriel
Part of the Immunology and Medicine book series (IMME, volume 9)


Warts are cutaneous or mucosal proliferations induced after infection by papillomavirus — a small DNA virus. Papillomaviruses have been the subject of interest, but of relatively limited experimental investigation until recently, primarily due to the inability to infect cells in culture and to obtain vegetative viral growth. The application of molecular virological techniques (cloning and sequencing) has resulted in the demonstration of a remarkable plurality in the papillomaviruses particularly in human infections. It is now evident that multiple types of HPV exist1,2 and that infection of different squamous epithelial surfaces, e.g. skin, cervix, penis and buccal mucosa, is associated with specific HPV types3. Interest in these viruses has been intensified by the evidence that HPV infection is associated with genital, oral and laryngeal cancers4.


Human Papilloma Virus Genital Wart Human Papilloma Virus Molluscum Contagiosum Epidermodysplasia Verruciformis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Gissmann, L., Pfister, H. and zur Hausen, H. (1977). Human papilloma viruses (HPV): characterisation of 4 different isolates.Virology,76, 569–80PubMedCrossRefGoogle Scholar
  2. 2.
    Orth, G., Favre, M. and Croissant, O. (1977). Characterisation of a new type of human papillomavirus that causes skin warts.J. Virol,24, 108–20PubMedGoogle Scholar
  3. 3.
    McCance, D. J. (1986). Human papillomaviruses and cancer.Biochim. Biophys. Acta,823, 195–205PubMedGoogle Scholar
  4. 4.
    zur Hausen, H. (1986). Papillomaviruses in human genital cancer: established results and prospects for the future. In Peto, R. and zur Hausen, H. (eds.).Viral Etiology of Cervical Cancer, Banbury Report,21, pp. 327–323. (Cold Spring Harbor Laboratory)Google Scholar
  5. 5.
    Gissmann, L., de Villiers, E-M. and zur Hausen, H. (1982). Analysis of human genital warts (condylomata acuminata) and other genital tumours for human papillomavirus type 6 DNA.Int. J. Cancer,29, 143–6PubMedCrossRefGoogle Scholar
  6. 6.
    Gissmann, L., Wolnik, L., Ikenburg, H., Koldovsky, W., Schnurch, H. and zur Hausen, H. (1983). Human papillomavirus types 6 and 11 DNA sequences in genital and laryngeal papillomas and in some cervical cancers.Proc. Natl Acad. Sci. USA,80, 560–3PubMedCrossRefGoogle Scholar
  7. 7.
    Durst, M., Gissmann, L., Ikenberg, H. and zur Hausen, H. (1983). A new type of papillomavirus DNA from a cervical carcinoma and its prevalence in genital cancer biopsies from different geographic regions.Proc. Natl Acad. Sci. USA,80, 3812–15PubMedCrossRefGoogle Scholar
  8. 8.
    Boshart, M. L., Gissmann, H., Ikenberg, W., Scheurlen, A., Kleinheinz, A. and zur Hausen, H. (1984). A new type of papillomavirus DNA, its presence in genital cancer biopsies and in cell lines derived from cervical cancer.EM BO J,3, 1151–7Google Scholar
  9. 9.
    McCance, D. J., Kalache, K., Ashdown, K., Andrade-Menezes, F., Smith, P. and Doll, R. (1986). Human papillomavirus types 16 and 18 in carcinomas of the penis from Brazil.Int. J. Cancer,37, 55–60PubMedCrossRefGoogle Scholar
  10. 10.
    Lorincz, A. T., Lancaster, W. D., Kurman, R. J., Jenson, A. B. and Temple, G. F. (1986). Characterisation of human papillomaviruses in cervical neoplasms and their detection in routine clinical screening. In Peto, R. and zur Hausen, H. (eds.).Viral Etiology of Cervical Cancer, Banbury Report,21, pp. 225–37. (Cold Spring Harbor Laboratory).Google Scholar
  11. 11.
    Giri, I. and Danos, O. (1986). Structure of Papillomavirus genomes from sequence data to biological properties.Trends Genet,2, 221–4CrossRefGoogle Scholar
  12. 12.
    Chen, E. Y., Howley, P. M., Levinson, A. D. and Seeburg, P. H. (1982). The primary structure and genetic organisation of the bovine papillomavirus type 1 genome.Nature,229, 529–34CrossRefGoogle Scholar
  13. 13.
    Danos, O., Katinka, M. and Yaniv, M. (1982). Human papillomavirus la complete DNA sequence: a novel type of genome organisation among papovaviridiae,EM BO J,1, 231–6Google Scholar
  14. 14.
    Lowy, D. R., Dvoretzky, I., Shober, R., Law, M. F., Engel, L. and Howley, P. M. (1980). In vitro tumorigenic transformation by a defined subgenomic fragment of bovine papillomavirus DNA.Nature,287, 72–5PubMedCrossRefGoogle Scholar
  15. 15.
    Doorbar, J., Campbells, D., Grand, R. J. A. and Gallimore, P. H. (1986). Identification of the human papillomavirus-la E4 gene products.EM BO J,5, 355–62Google Scholar
  16. 16.
    Schwarz, E., Freese, U.K., Gissmann, L., Mayer, W., Roggenbuck, B., Stramlau, A. and zur Hausen, H. (1985). Structure and transcription of human papillomavirus sequences in cervical carcinoma cells.Nature,314, 111–14PubMedCrossRefGoogle Scholar
  17. 17.
    Yee, C., Krishnan-Hewlett, I., Baker, C. C., Schlegel, R. and Howley, P. M. (1985). Presence and expression of human papillomavirus sequences in human cervical carcinoma lines.Am. J. Pathol,119, 361–6PubMedGoogle Scholar
  18. 18.
    Matlashewski, G., Schneider, J., Banks, L., Jones, N., Murray, A. and Crawford, L. (1987). Human papillomavirus type 16 DNA co-operates with activated ras in transforming primary cellsEMBO J,6, 1741–6Google Scholar
  19. 19.
    Pilacinski, W. P., Glassmann, D. L., Glassmann, K. F., Reed, D. E., Lum, M. A., Marshall, R. F., Muscoplat, C. C. and Faras, A. J. (1986). Immunisation against BPV infection.CIBA Foundation Symposium,120, 136–48PubMedGoogle Scholar
  20. 20.
    Kreider, J. W. and Bartlett, G. L. (1981). The Shope Papilloma-carcinoma complex of rabbits: a model system of neoplastic progression and spontaneous regression.Adv. Cancer Res,35, 81–110PubMedCrossRefGoogle Scholar
  21. 21.
    Jenson, A. B., Lancaster, W. D., Hartmann, D. P. and Shaffer, E. L. (1982). Frequency and distribution of papillomavirus structural antigens in verrucae, multiple papillomas and condylomata of the oral cavity.Am. J. Pathol,107, 212–18PubMedGoogle Scholar
  22. 22.
    Grussendorf-Conen, E. (1986). In situ hybridisation with papillomavirus DNA in genital lesions. In Peto, R. and zur Hausen, H. (eds.). Viral Etiology of Cervical Cancer.Banbury Report 21, pp. 239–46. (Cold Spring Harbor Laboratory)Google Scholar
  23. 23.
    Jenson, A. B., Rosenthal, J. D., Olson, C., Pass, F., Lancaster, W. D. and Shah, K. (1980). Immunological relatedness of papillomaviruses from different species.J. Natl. Cancer Inst,64, 495–500PubMedGoogle Scholar
  24. 24.
    Dyson, J. L., Walker, P. G. and Singer, A. (1984). Human papillomavirus infection of the uterine cervix: histological appearance in 28 cases identified by immunohistochemical techniques.J. Clin. Pathol,37, 126–30PubMedCrossRefGoogle Scholar
  25. 25.
    Gupta, J., Gendelman, H. E., Naghasnfar, Z., Gupta, P., Rosensheim, N., Sawada, E., Woodruff, J. D. and Shah, K. V. (1985). Specific identification of human papillomavirus type in cervical smears and paraffin sections by in situ hybridisation with radioactive probes: a preliminary communication.Int. J. Gynecol. Pathol,4, 211PubMedCrossRefGoogle Scholar
  26. 26.
    Beckman, A. M., Myerson, D., Daline, J. R., Kiviat, N. B., Fenoglio, C. M. and McDougall, J. K. (1985). Detection of human papillomavirus DNA in carcinomas by in situ hybridisation with biotinylated probes.J. Med. Virol,16, 265–73CrossRefGoogle Scholar
  27. 27.
    Stoler, M. H. and Broker, T. R. (1986). In situ hybridisation detection of human papillomavirus DNAs and messenger RNAs in genital condylomas and a cervical carcinoma.Human Pathol 17, 1250 - 8CrossRefGoogle Scholar
  28. 28.
    Palefsky, J., Winkler, B., Nizet, V., Kidd, J. L. and Schoolnik, G. K. (1986). Detection of HPV proteins, the synthetic peptide approach in Steinberg, B. M., Brandsma, J. and Taichman, L. (eds.).Papillomaviruses Cancer Cells, Vol.5, pp. 101–103. (Cold Spring Harbor)Google Scholar
  29. 29.
    Kirchner, H. (1986). Immunobiology of human papillomavirus infection.Progr. Med. Virol,33, 1–41Google Scholar
  30. 30.
    Morison, W. L. (1975). Viral warts, herpes simplex and herpes zoster in patients with secondary immune deficiences and neoplasms.Br. J. Dermatol,92, 625–30PubMedCrossRefGoogle Scholar
  31. 31.
    Perry, T. L. and Hartmann, L. (1974). Warts in diseases with immune defects.Cutis,13, 359–62Google Scholar
  32. 32.
    Zinu, K-H., Belohradsky, H. (1977). Wiscott-Aldrich Syndrome mit Verrucae vulgares.Hautarzt,28, 664–97Google Scholar
  33. 33.
    Ormerod, A. D., Finlay, A. Y., Knight, A. G., Matthews, N., Stark, J. M. and Gough, J. (1983). Immune deficiency and multiple viral warts; possible variant of the Wiskott-Aldrich syndrome.Br. J. Dermatol,108, 211–15PubMedCrossRefGoogle Scholar
  34. 34.
    Reid, T. M. S., Fraser, N. G. and Kernohan, I. R. (1976). Generalised warts and immune deficiency.Br. J. Dermatol,95, 559–64Google Scholar
  35. 35.
    Koranda, F. C., Dehmel, E. M., Kahn, G. and Penn, I. (1974). Cutaneous complications in immunosuppressed renal homograft recipients.J. Am. Med. Assoc,229, 419–24CrossRefGoogle Scholar
  36. 36.
    Spencer, E. S. and Andersen, H. K. (1970). Clinically evident non-terminal infections with herpes virus and the wart virus in immunosuppressed renal allograft recipients.Br. Med. J, 1, 251–4CrossRefGoogle Scholar
  37. 37.
    Ingelfinger, J. R., Grupe, W. E., Topor, M. and Levey, R. H. (1977). Warts in pediatric renal transplant population.Dermatologica, 155, 7–12PubMedCrossRefGoogle Scholar
  38. 38.
    Marshall, V. (1974). Premalignant and malignant skin tumours in immunosuppressed patients.Transplantation, 17, 272–5PubMedCrossRefGoogle Scholar
  39. 39.
    Mullen, D. L., Silverberg, S. G., Penn, I. and Hammond, W. S. (1976). Squamous cell carcinoma of the skin and lip in renal homograft recipients.Cancer, 37, 729–34PubMedCrossRefGoogle Scholar
  40. 40.
    Hoover, R. and Fraumeri, J. F. (1973). Risk of cancer in renal transplant patients.Lancet, 2, 55PubMedCrossRefGoogle Scholar
  41. 41.
    Porreco, R., Penn, I., Droegemuller, W., Greer, B. and Makowski, M. (1975). Gynaecologic malignancies in immunosuppressed organ homograft recipients.Obstet. Gynecol, 45, 359–64PubMedGoogle Scholar
  42. 42.
    Shokri-Tabibzadeh, S., Koss, L. G., Molnar, J. and Romney, S. (1981). Association of human papillomavirus with neoplastic processes in the genital tract of 4 women with impaired immunity.Gynaecol. Oncol, 12, 129–40CrossRefGoogle Scholar
  43. 43.
    Orth, G. and Favrre, M. (1985).Clin. Dermatol, 3, 27–42PubMedCrossRefGoogle Scholar
  44. 44.
    Evans, C. A., Weiser, R. S. and Ito, Y. (1962). Antiviral and antitumor immunologic mechanisms operative in the Shope Papilloma-Carcinoma system. Cold Spring Harbor,Symp. Quant. Biol, 27, 453–62Google Scholar
  45. 45.
    Evans, C. A., Gorman, L. R., Ito, Y. and R. S., Weiser. (1962). Antitumor immunity in the Shope papilloma-carcinoma complex of rabbits. I. Papilloma regression induced by homologous and autologous tissue vaccines.J. Natl. Cancer Inst, 29, 277–86PubMedGoogle Scholar
  46. 46.
    Kreider, J. W. (1963). Studies on the mechanism responsible for the spontaneous regression of the Shope rabbit papilloma.Cancer Res, 23, 1593–9PubMedGoogle Scholar
  47. 47.
    Evans, C. A. and Thomsen, J. J. (1969). Antitumor immunity in the Shope-Papilloma- Carcinoma complex. IV. Search for a transmissible factor increasing the frequency of tumor regression.J. Natl. Cancer Inst, 42, 477–84PubMedGoogle Scholar
  48. 48.
    Almeida, J. D. and Goffe, A. P. (1965). Antibody to wart virus in human sera demonstrated by electron microscopy and precipitin tests. Lancet, 2, 1205PubMedCrossRefGoogle Scholar
  49. 49.
    Ogilvie, M. M. (1970). Serological studies with human (papova) wart virus.J. Hyg, 68, 479–90CrossRefGoogle Scholar
  50. 50.
    Matthews, R. S. and Shirodaria, P. V. (1973). Study of regressing warts by immunofluorescence.Lancet, 1, 689–91PubMedCrossRefGoogle Scholar
  51. 51.
    Morison, W. L. (1975). In vitro assay of immunity to wart antigen.Br. J. Dermatol, 93, 545–52PubMedCrossRefGoogle Scholar
  52. 52.
    Baird, P. J. (1983). Serological evidence for the association of papillomavirus and cervical neoplasia.Lancet, 2, 17–18PubMedCrossRefGoogle Scholar
  53. 53.
    Firzlaff, J. M., Hsia, C. N., Halbert, C. and Galloway, D. A. (1986). Polyclonal antibodies of Human papillomavirus 6b and 16: bacterially derived fusion proteins. In Steinberg, B. M., Brandsma, J. and Taichman, L. (eds.).Papillomaviruses, Cancer Cells, Vol. 5, pp. 105–11 (Cold Spring Harbor)Google Scholar
  54. 54.
    Li, C. C. H., Shah, K., Seth, A. and Gilden, R. V. (1987). Identification of the human papillomavirus type 6b LI open reading frame protein in condylomas and corresponding antibodies in human sera.Virol, 61, 2684–90Google Scholar
  55. 55.
    Pyrhonen, S. and Johansson, E. (1975). Regression of warts. An immunological study.Lancet, 1, 592–5PubMedCrossRefGoogle Scholar
  56. 56.
    Cubie, H. A. (1972). Serological studies in a student population prone to infection with human papilloma virus.J. Hyg, 70, 677–90CrossRefGoogle Scholar
  57. 57.
    Cubie, H. A. and Norval, M. (1987). Human and cellular immunity to papillomavirus in patients with cervical dysplasia.J. Gen. Virol. (In press)Google Scholar
  58. 58.
    Invanyi, L. and Morison, W. L. (1976). In vitro lymphocyte stimulation by wart antigen in man.Br. J. Dermatol, 94, 523–7CrossRefGoogle Scholar
  59. 59.
    Lee, A. K. Y. and Eisinger, M. (1976). Cell mediated immunity (CMI) to human wart virus and wart associated tissue antigens.Clin. Exp. Immunol, 26, 419–24PubMedGoogle Scholar
  60. 60.
    Tagami, H., Ogino, A., Takigawa, M., Imamura, S. and Ofuji, S. (1974). Regression of plane warts following spontaneous inflammation: a histopathological study.Br. J. Dermatol, 90, 147–54PubMedCrossRefGoogle Scholar
  61. 61.
    Berman, A. and Winkelman, R. K. (1977). Flat warts undergoing involution.Arch. Dermatol, 113, 1219–21PubMedCrossRefGoogle Scholar
  62. 62.
    Aiba, S., Rokugo, M. and Tagami, H. (1986). Immunohistologic analysis of the phenomenon of spontaneous regression of numerous flat warts.Cancer, 58, 1246–51PubMedCrossRefGoogle Scholar
  63. 63.
    Tagami, H., Oguchi, M. and Ofuji, S. (1980). The phenomenon of spontaneous regression of numerous flat warts. Immunohistological studies.Cancer, 45, 2557–63PubMedCrossRefGoogle Scholar
  64. 64.
    Choi, K. L. and Sauder, D. N. (1986). The role of Langerhan’s cells and keratinocytes in epidermal immunity.J. Leuk. Biol, 39, 343–58Google Scholar
  65. 65.
    Morris, H. H. B., Gatter, K. C., Stein, H. and Mason, D. Y. (1983). Langerhan’s cells in human cervical epithelium: an immunohistological study.Br. J. Obstet. Gynaecol, 90, 400–11PubMedCrossRefGoogle Scholar
  66. 66.
    Tay, S. K., Jenkins, D., Maddox, P., Campion, M. and Singer, A. (1987). Subpopulations of Langerhan’s cells in cervical neoplasia.Br. J. Obstet. Gynaecol, 94, 10–15PubMedCrossRefGoogle Scholar
  67. 67.
    Tay, S. K., Jenkins, Maddox, P. and Singer, A. (1987). Lymphocyte phenotypes in cervical intra-epithelial neoplasia and human papillomavirus infection.Br. J. Obstet. Gynaecol, 94, 16–21PubMedCrossRefGoogle Scholar
  68. 68.
    Wilkin, J. K. (1977). Molluscum contagiosum venereum in a women’s out-patient clinic.Am. J. Obstet. Gynecol, 128, 531–5PubMedGoogle Scholar
  69. 69.
    Sexually transmitted diseases. (1973). Extracts from the annual report of the Chief Medical Officer to the Department of Health and Social Security 1971.Br. J. Vener. Dis, 49, 89–95Google Scholar
  70. 70.
    Sexually transmitted diseases. (1983). Extracts from the annual report of the chief Medical Officer to the Department of Health and Social Security 1980.Br. J. Vener. Dis, 59, 134–7Google Scholar
  71. 71.
    Blank, H. and Rake, H. (1955). Viral and rickettsial diseases of the skin, eye and mucous membranes of man. 182–192,London, J. and A. Churchill Google Scholar
  72. 72.
    Blank, H. (1952). Virus induced tumours of human skin (warts, molluscum contagiosum).Ann. NY Acad. Sci, 54, 1226PubMedCrossRefGoogle Scholar
  73. 73.
    Mitchell, J. C. (1953). Observations on the virus of molluscum contagiosum.Br. J. Exp. Pathol, 34, 44–9PubMedGoogle Scholar
  74. 74.
    Neva, F. A. (1962). Studies on molluscum contagiosum. Observations on the cytopathic effect of molluscum suspensions in vitro.Arch. Int. Med, 110, 720–5Google Scholar
  75. 75.
    Raskin, J. (1963). Molluscum contagiosum: tissue culture and serologic study.Arch. Dermatol, 87, 552–9PubMedGoogle Scholar
  76. 76.
    Epstein, W. L., Senecal, I. P. and Massing, A. M. (1961). An antigen in lesions of molluscum contagiosum.Nature, 191, 509PubMedCrossRefGoogle Scholar
  77. 77.
    Shirodaria, P. V. and Matthews, R. S. (1977). Observations on the antibody responses in molluscum contagiosum.Br. J. Dermatol, 96, 29–37PubMedCrossRefGoogle Scholar
  78. 78.
    Epstein, W. L., Conant, M. A. and Krasnobrod, H. (1966). Moluscum contagiosum. Normal and virus infected epidermal cell kinetics.J. Invest. Dermatol, 46, 91–9PubMedGoogle Scholar
  79. 79.
    Postlethwaite, R. (1970). Molluscum contagiosum: a review.Arch. Environ. Health, 21, 432–52PubMedGoogle Scholar
  80. 80.
    Brown, S. T., Nailey, J. F. and Kraus, S. J. (1981).Molluscum contagiosum. Sex. Transm. Dis, 8, 227–34CrossRefGoogle Scholar
  81. 81.
    Felman, Y. M. and Nikitas, J. A. (1983). Sexually transmitted molluscum contagiosum. Symposium on sexually transmitted diseases.Dermatol. Clin., 1, 103–10Google Scholar

Copyright information

© Kluwer Academic Publishers 1988

Authors and Affiliations

  • M. A. Stanley
  • J. D. Oriel

There are no affiliations available

Personalised recommendations